Aktis Oncology, Inc.

AKTS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Sep 24, 2026 4
144 Sep 23, 2026
10-Q Aug 13, 2026 10-Q
8-K Aug 13, 2026 8-K
4 Jul 21, 2026 4
4 Jul 20, 2026 4
144 Jul 20, 2026
144 Jul 17, 2026
4 Jul 10, 2026 4
4 Jul 10, 2026 4
144 Jul 8, 2026
144 Jul 8, 2026
SCHEDULE 13G May 14, 2026
10-Q May 11, 2026 10-Q
8-K May 11, 2026 8-K
4 Apr 16, 2026 4
3 Apr 16, 2026 3
8-K Apr 16, 2026 8-K
8-K Mar 30, 2026 8-K
10-K Mar 30, 2026 10-K
SCHEDULE 13D Jan 20, 2026
SCHEDULE 13D Jan 20, 2026
SCHEDULE 13D Jan 15, 2026
3 Jan 15, 2026 3
4 Jan 14, 2026
← Newer Page 1 of 3 · 62 filings Older →